Start Forschung Personen Publikationen

Publikationen

Prof. Dr. Andreas Meyer-Lindenberg

Alnæs D, Kaufmann T, van der Meer D, Córdova-Palomera A, Rokicki J, Moberget T, Bettella F, Agartz I, Barch DM, Bertolino A, Brandt CL, Cervenka S, Djurovic S, Doan NT, Eisenacher S, Fatouros-Bergman H, Flyckt L, Di Giorgio A, Haatveit B, Jönsson EG, Kirsch P, Lund MJ, Meyer-Lindenberg A, Pergola G, Schwarz E, Smeland OB, Quarto T, Zink M, Andreassen OA, Westlye LT, Karolinska Schizophrenia Project Consortium . Brain Heterogeneity in Schizophrenia and Its Association With Polygenic Risk. JAMA Psychiatry. 2019 Apr 10. [Epub ahead of print]
Böge K, Karnouk C, Hahn E, Schneider F, Habel U, Banaschewski T, Meyer-Lindenberg A, Salize HJ, Kamp-Becker I, Padberg F, Hasan A, Falkai P, Rapp MA, Plener PL, Stamm T, Elnahrawy N, Lieb K, Heinz A, Bajbouj M. Mental health in refugees and asylum seekers (MEHIRA): study design and methodology of a prospective multicentre randomized controlled trail investigating the effects of a stepped and collaborative care model. Eur Arch Psychiatry Clin Neurosci. 2019 Feb 22. [Epub ahead of print]
Deuschle M, Scheydt S, Hirjak D, Borgwedel D, Erk K, Hennig O, Heser M, Pfister M, Leweke MF, Meyer-Lindenberg A. [Track treatment in psychiatry: the CIMH track model to overcome sector boundaries]. Nervenarzt. 2019 Apr 2. [Epub ahead of print]
Durstewitz D, Koppe G, Meyer-Lindenberg A. Deep neural networks in psychiatry. Mol Psychiatry. 2019 Feb 15. [Epub ahead of print]
Englisch S, Jung HS, Lewien A, Becker A, Nowak U, Braun H, Eisenacher S, Thiem J, Meyer-Lindenberg A, Zink M. Response to Agomelatine Treatment is Independent of Smoking Status and Dosage: Results From the AGOPSYCH Study. Pharmacopsychiatry. 2019 52(3):142-146. Epub 2018 May 7.
Hazo JB, Brunn M, Wikes T, McDaid D, Dorsey M, Demotes-Mainard J, van der Feltz-Cornelis CM, Wahlbeck K, Knappe S, Meyer-Lindenberg A, Obradors-Tarragó C, Haro JM, Leboyer M, Chevreul K, Roamer Consortium . European mental health research resources: Picture and recommendations of the ROAMER project. Eur Neuropsychopharmacol. 2019 29(2):179-194. Epub 2018 Dec 19.
Hirjak D, Gass P, Deuschle M, Leweke FM, Böhringer A, Schenkel N, Borgwedel D, Heser M, Breisacher A, Meyer-Lindenberg A. [The CIMH track concept in the treatment of psychotic disorders]. Nervenarzt. 2019 Apr 11. [Epub ahead of print]
Hirjak D, Leweke FM, Deuschle M, Staudter C, Borgwedel D, Coenen-Daniel M, Heser M, Erk K, Beivers A, Meyer-Lindenberg A. [The CIMH Track Concept in Psychiatry: Syndrome-specific Treatment across Modalities - Part 2 - Practical implementation]. Fortschr Neurol Psychiatr. 2019 Feb 7. [Epub ahead of print]
Koethe D, Pahlisch F, Hellmich M, Rohleder C, Mueller JK, Meyer-Lindenberg A, Torrey EF, Piomelli D, Leweke FM. Familial Abnormalities of Endocannabinoid Signaling in Schizophrenia. World J Biol Psychiatry. 2019 20(2):117-125. Epub 2018 Mar 9.
Leweke FM, Hirjak D, Staudter C, Borgwedel D, Coenen-Daniel M, Heser M, Erk K, Juckel G, Beivers A, Meyer-Lindenberg A. [The CIMH Track Concept in Psychiatry: Syndrome-specific Treatment across Modalities - Part 1 - Theoretical background]. Fortschr Neurol Psychiatr. 2019 Feb 14. [Epub ahead of print]
Schmidt SJ, Hurlemann R, Schultz J, Wasserthal S, Kloss C, Maier W, Meyer-Lindenberg A, Hellmich M, Muthesius-Digón A, Pantel T, Wiesner PS, Klosterkötter J, Ruhrmann S, Hirjak D, ESPRIT-B1 Group . Multimodal prevention of first psychotic episode through N-acetyl-l-cysteine and integrated preventive psychological intervention in individuals clinically at high risk for psychosis: Protocol of a randomized, placebo-controlled, parallel-group trial. Early Interv Psychiatry. 2019 Feb 19. [Epub ahead of print]
Schwarz E, Doan NT, Pergola G, Westlye LT, Kaufmann T, Wolfers T, Brecheisen R, Quarto T, Ing AJ, Carlo PD, Gurholt TP, Harms RL, Noirhomme Q, Moberget T, Agartz I, Andreassen OA, Bellani M, Bertolino A, Blasi G, Brambilla P, Buitelaar JK, Cervenka S, Flyckt L, Frangou S, Franke B, Hall J, Heslenfeld DJ, Kirsch P, McIntosh AM, Nöthen MM, Papassotiropoulos A, de Quervain DJ, Rietschel M, Schumann G, Tost H, Witt SH, Zink M, Meyer-Lindenberg A, IMAGEMEND Consortium, Karolinska Schizophrenia Project (KaSP) Consortium . Reproducible grey matter patterns index a multivariate, global alteration of brain structure in schizophrenia and bipolar disorder. Transl Psychiatry. 2019 9(1):12.
Schweiger JI, Bilek E, Schäfer A, Braun U, Moessnang C, Harneit A, Post P, Otto K, Romanczuk-Seiferth N, Erk S, Wackerhagen C, Mattheisen M, Mühleisen TW, Cichon S, Nöthen MM, Frank J, Witt SH, Rietschel M, Heinz A, Walter H, Meyer-Lindenberg A, Tost H. Effects of BDNF ValMet genotype and schizophrenia familial risk on a neural functional network for cognitive control in humans. Neuropsychopharmacology. 2019 44(3):590-597. Epub 2018 Oct 25.
van den Bosch M, Meyer-Lindenberg A. Environmental Exposures and Depression: Biological Mechanisms and Epidemiological Evidence. Annu Rev Public Health. 2019 40:239-259. Epub 2019 Jan 11.


Zentralinstitut für Seelische Gesundheit (ZI) - https://www.zi-mannheim.de